Model Generation Solutions INSIGHTS

CRISPR/Cas9 Intellectual Property Landscape for Rodent Model Generation

photo from CRISPR/Cas9 Intellectual Property Landscape for Rodent Model Generation

CRISPR/Cas9 is an extremely useful tool for both academic and commercial researchers. It is also widely used in the generation of custom mice and rats from licensed animal model vendors. However, there are multiple patents covering this technology and understanding the differences between them is essential before utilizing CRISPR/Cas9 for model generation. This Insight will focus on two key CRISPR/Cas9 patents and how they have influenced model...  Read More

Utilizing CRISPR/Cas9 as a genome editing therapeutic in mouse models of human disease

photo from Utilizing CRISPR/Cas9 as a genome editing therapeutic in mouse models of human disease

The application of CRISPR/Cas9 as a mammalian gene editing technology has tremendously matured over the last decade. This has paved the way for the development of CRISPR/Cas9 as therapeutic tool to treat human genetic disease, while making it easier to create the genetically modified animal models required to screen potential therapeutics. In Vivo CRISPR/Cas9-Based Therapeutics in Clinical Trials Current clinical trials utilizing this technology focus on gene...  Read More

Overview of Genetic Modification Techniques

photo from Overview of Genetic Modification Techniques

The first genetically-modified mouse capable of transferring its modified genome to offspring was developed in the early 1980s. Since then, multiple genetic modification techniques have been developed to modify rodent genomes and are still commonly used today. Random and targeted transgenesis are commonly used today to study the effects of incorporating exogenous DNA for the purposes of expressing proteins not normally present in mice and rats, while...  Read More

A Simple Guide to CRISPR

photo from A Simple Guide to CRISPR

In the short time since the introduction of CRISPR technology in 1987, it has proved to be a valuable tool. In 2018, there were over 17,000 publications on CRISPR gene editing technology compared to seven years earlier when there were less than 100 publications. The future is bright in how CRISPR will impact research, treatments, and cures. VOX recently published, A simple guide to CRISPR, one of...  Read More

CRISPR Patent Update: Broad vs. Berkeley

photo from CRISPR Patent Update: Broad vs. Berkeley

It was recently announced that the legal battle over the CRISPR/Cas9 patents is likely finished with the Broad Institute prevailing above UC Berkeley. This ongoing debate began in 2014 with multiple research groups and institutions claiming rights to the CRISPR/Cas9 technology. The researchers involved in this case are Dr. Jennifer Doudna (UC Berkeley) and Dr. Emmanuelle Charpentier (University of Vienna) who engineered the Cas9 endonuclease from a...  Read More

Application of CRISPR/Cas to the Generation of Genetically Engineered Mice White Paper

photo from Application of CRISPR/C<span style='text-transform: lowercase;'>as</span> to the Generation of Genetically Engineered Mice White Paper

UPDATE: This White Paper has been updated in 2018 to reflect the latest technological advances and usage recommendations of CRISPR/Cas in the generation of research models. CRISPR/Cas gene editing has emerged as a versatile technology for inducing precise genetic alterations in a number of different species, including mice and rats. Given the importance of genetically engineered mice in modeling human disease, the power of CRISPR has the...  Read More

The Advantages and Limitations of Easi-CRISPR

photo from The Advantages and Limitations of Easi-CRISPR

CRISPR/Cas9 genome editing technology enables the modification of the mouse and rat genomes with unprecedented simplicity and speed but is subject to limitations that restrict its application to the introduction of simple mutations such as constitutive knockout or point mutation alleles. Easi-CRISPR overcomes those limitations by using longer single-stranded DNA, offering researchers a faster and more efficient technology for targeted transgenesis and complex genetic modifications. Limitations of...  Read More

Deflating the CRISPR/Cas9 Off-Target Controversy

photo from Deflating the CRISPR/Cas9 Off-Target Controversy

UPDATE: The paper which originally tied CRISPR/Cas 9 to off-target mutations in the mouse genome has been retracted. More information is available here. The use of CRISPR/Cas9 has profoundly affected mouse genetics by reducing the cost and the timeline associated with the introduction of mutations in the genome. But is it possible that CRISPR isn't specific enough for the generation of genetically engineered animal models? Since its...  Read More

Webinar Q&A — Your Guide to the C57BL/6 Mouse

photo from Webinar Q&A — Your Guide to the C57BL/6 Mouse

Did you miss Dr. Philip Dubé's recent webinar, The Most Important Mouse in the World - Your Guide to the C57BL/6 Mouse? His presentation explored genetic diversity amongst C57BL/6 substrains, the implications for GEM models, and the utility of the C57BL/6 mouse in studies of metabolism, immunology, oncology and behavior. Due to time constraints, many of the questions researchers submitted to his Q&A session went unanswered. Here...  Read More

Here is what CRISPR, the number 62 and pigs have in common!

photo from Here is what CRISPR, the number 62 and pigs have in common!

In December of 2015, Taconic Biosciences published an Insight titled, What do CRISPR, the number 62, and pigs have in common? In that Insight, Dr. George Church of Harvard Medical School explained that his lab had edited 62 genes in pig embryos using CRISPR-Cas9. Their goal was to make pigs better candidates as organ donors for humans. Given their close anatomical size to humans, pigs are thought...  Read More